Inventor · Singapore, SG

Michael A. Crowe

14Patents

4h-index

21Co-inventors

56Inventor score

Filing activity: May 4, 2011 → Jul 19, 2021

Most-cited inventions

Patent	Title	Area	Cited by	Status
US9139821B2	Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs	Emerging Cross-Sectional Technologies	18	Active
US9388395B2	Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs	Emerging Cross-Sectional Technologies	15	Active
US9708588B2	Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs	Emerging Cross-Sectional Technologies	8	Active
US9598712B2	Chemical process for preparing spiroindolones and intermediates thereof	Emerging Cross-Sectional Technologies	6	Active
US9040262B2	Biocatalysts for ezetimibe synthesis	Chemistry; Metallurgy	4	Active
US9388391B2	Biocatalysts for Ezetimibe synthesis	Chemistry; Metallurgy	4	Active
US9644189B2	Biocatalysts for ezetimibe synthesis	Chemistry; Metallurgy	3	Active
US10053673B2	Biocatalysts for Ezetimibe synthesis	Chemistry; Metallurgy	2	Active
US10544400B2	Biocatalysts for ezetimibe synthesis	Chemistry; Metallurgy	1	Active
US10544402B2	Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs	Emerging Cross-Sectional Technologies	1	Active
US12378537B2	Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs	Emerging Cross-Sectional Technologies	0	Active
US11098291B2	Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs	Emerging Cross-Sectional Technologies	0	Active
US12110512B2	Biocatalysts for ezetimibe synthesis	Chemistry; Metallurgy	0	Active
US10995320B2	Biocatalysts for Ezetimibe synthesis	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.